Calculate your body mass index (BMI)

Weight

Feet

Inches

Your BMI

Back to list

Palmoplantar Pustulosis


Study Dates: TBD - TBD

Study Number

231945

Group

●  Dermatology

Compensation

Up to: $2,240

Gender

Male, Female, Smoker, Non-Smoker

Age

18+

Additional Information

Screening and outpatient study dates are flexible.

Details

The Baltimore Early Phase Unit is currently seeking volunteers with palmoplantar pustulosis (PPP) to participate in an outpatient clinical research trial evaluating a new investigational drug. The study involves 1 screening visit, 4 doses of the investigational medication (approximately every 2 weeks), and 10 outpatient visits. You may be randomized to receive the study medication or placebo. Qualified participants must have a current diagnosis of PPP (for at least 6 months) and have active lesions on the palms and/or soles. Additionally, participants must be able and willing to washout of topical medicated treatments (i.e. Clobex) for 14 days and other systemic or biologic treatments (i.e. prescription medication such as Enbrel, Remicade, etc.) for 28 days-3 months (depending on the medication).Call 667.210.5353 or 667.210.5374